Cargando…
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
BACKGROUND: Mesenchymal stromal cells (MSCs, “adult stem cells”) have been widely used experimentally in a variety of clinical contexts. There is interest in using these cells in critical illness, however, the safety profile of these cells is not well known. We thus conducted a systematic review of...
Autores principales: | Lalu, Manoj M., McIntyre, Lauralyn, Pugliese, Christina, Fergusson, Dean, Winston, Brent W., Marshall, John C., Granton, John, Stewart, Duncan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485008/ https://www.ncbi.nlm.nih.gov/pubmed/23133515 http://dx.doi.org/10.1371/journal.pone.0047559 |
Ejemplares similares
-
Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta‐Analysis
por: Lalu, Manoj M., et al.
Publicado: (2018) -
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
por: Thompson, Mary, et al.
Publicado: (2020) -
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017) -
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014) -
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016)